Table 2.
Category | Class | Main background disease | Representative drug name | |
---|---|---|---|---|
Antidepressants | SSRIs* SNRIs** NaSSAs*** DNRIs**** Tetracyclic antidepressants Tricyclic antidepressants |
Depression | Fluvoxamine, Paroxetine Sertraline Milnacipran Mirtazapine Bupropion Maprotiline Amoxapine Nortriptyline |
|
| ||||
Dopamine stimulants | Dopamine agonists | Parkinson's disease, depression (?) | Bromocriptine Pramipexrole Ropinirole Amantadine |
|
MAO-B inhibitor | Selegiline | |||
| ||||
Antipsychotic agents | Atypical antipsychotic agents | Negative symptoms (apathy-like symptoms) of schizophrenia | Clozapine, Risperidone, Olanzapine, Quetiapine, Ziprasidone |
|
| ||||
Psychostimulants | Dopaminergic agents | Primary apathy or apathy syndrome | Methylphenidate Pemoline Amphetamine Modafinil |
|
| ||||
Antidementia agents | Cholinesterase inhibitors | Alzheimer's disease | Donepezil Galantamine Rivastigmine Metrifonate Tacrine |
|
Pyrrolidone-type nootropic agent | Stroke, Alzheimer's disease | Nefiracetam | ||
| ||||
Cerebral circulation and metabolism stimulants | Ergot alkaloid | Stroke | Nicergoline | |
Antiplatelet drugs | Phosphodiesterase inhibitor | Cilostazol |
*Selective serotonin reuptake inhibitors: there have been a few reports that SSRIs are not effective for apathy. **Serotonin-noradrenaline reuptake inhibitors. ***Noradrenergic and specific serotonergic antidepressants. ****Noradrenaline-dopamine reuptake inhibitors.